Session date: 
01/26/2021 - 11:30am to 1:00pm

Pharmacy Grand Rounds 

  • ACPE Universal Activity Number (UAN): JA0000238-0000-21-056-L01-P
  • Session Type: Knowledge-based
  • CE Credits: A maximum of 1.0 contact hour (1.0 CEU) for the following: 
    • AAPA Category 1 CME Credits
    • ACPE
    • AMA PRA Category 1 Credits™
    • ANCC
  • Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Visit posting for connection information

COURSE DESCRIPTION

Naloxone is a potentially lifesaving medication that can be easily administered to those who overdose on opioids. Join the next Primary Care Grand Rounds to hear from the Mayo Clinic Opioid Stewardship Program Subcommittee's guest, Bonnie Milas, M.D., a professor of clinical anesthesiology and critical care in the Perelman School of Medicine at the University of Pennsylvania. Halena Gazelka, M.D., chair of the Opioid Stewardship Program Subcommittee, and Benjamin Lai, M.B., B.Ch., BAO, a member of the Opioid Stewardship Program Subcommittee, will host the discussion.

Dr. Milas, driven by the tragic loss of her two sons to opioid overdoses, advocates for breaking the stigma of opioid use disorder and making naloxone readily available. She will share her message along with a recovering heroin user whose life was saved by naloxone.

LEARNING OBJECTIVES
At the conclusion of this knowledge-based CE session, participants should be able to:

  • explain how a live saving treatment can be used to treat opioid overdose.
  • describe how to advocate for breaking the stigma and making the drug more readily available.

FACULTY INFORMATION
Julie Cunningham, Pharm.D., R.Ph.
Casey Clements, M.D., Ph.D.
Halena Gazelka, M.D.
Benjamin Lai, M.B., B.Ch., BAO
Bonnie Milas, M.D., Visiting Professor from Perelman School of Medicine at the University of Pennsylvania

DISCLOSURE STATEMENTS
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

No relationships:
Julie Cunningham, Pharm.D., R.Ph.
Casey Clements, M.D., Ph.D.
Halena Gazelka, M.D.
Benjamin Lai, M.B., B.Ch., BAO
Bonnie Milas, M.D., Visiting Professor from Perelman School of Medicine at the University of Pennsylvania

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session. 

Members include:

  • Jennifer Elmer, DNP, APRM, CCNS, FCCM
  • Michael Huckabee, MPAS, PA-C, PhD
  • Sarah Jane Kotval, BSW
  • Wayne (Nick) Nicholson, MD, PharmD, BCPS
  • Garrett Schramm, PharmD, BCPS
  • Lee Skrupky, PharmD, BCPS
  • Brenda Stellmaker
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota